Lantheus Advances Pediatric Cardiovascular Imaging with DEFINITY
Lantheus Holdings, Inc. celebrates FDA approval for DEFINITY as an ultrasound enhancing agent in pediatric patients with suboptimal echocardiograms. Rigorous clinical trials affirm DEFINITY’s efficacy and safety in this population, marking a significant stride…
Continue Reading